Calcium is a vital mineral that plays a crucial role in various physiological processes. This article aims to delve into its significance in bone metabolism, providing a comprehensive understanding for healthcare professionals.
Calcium is the primary component of bones and teeth, constituting approximately 99% of the body's total calcium. It aids in the construction of a healthy skeletal system and the maintenance of bone density, thereby preventing osteoporosis and fractures.
Calcium homeostasis, regulated by hormones such as parathyroid hormone (PTH), vitamin D, and calcitonin, is integral to bone metabolism. The interplay between these hormones ensures a constant level of calcium in the blood, which is crucial for normal cellular functions. Any disruption in this balance can lead to bone diseases.
The absorption of dietary calcium is a critical process that occurs predominantly in the duodenum and jejunum. It is facilitated by active transport and passive diffusion, with vitamin D playing a pivotal role in the former. Factors such as age, vitamin D status, and dietary components can significantly influence calcium absorption.
Calcium supplementation is often recommended for individuals at risk of osteoporosis or those with inadequate dietary intake. However, the benefits and risks of calcium supplements should be carefully considered, as excessive intake can lead to hypercalcemia and kidney stones.
In conclusion, calcium plays a vital role in bone metabolism and overall bone health. Understanding the mechanisms of calcium homeostasis, absorption, and the implications of supplementation is crucial for healthcare professionals in managing bone health effectively. Continuous research in this field will further elucidate the complex role of calcium in bone metabolism.
1.
Year in Review: Non-Small Cell Lung Cancer
2.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
5.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
1.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
2.
The Danger of Methemoglobinemia and How to Prevent It
3.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Thromboprophylaxis In Medical Settings
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation